IRIS
BIANCO, ANGELO RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.072
NA - Nord America 2.852
EU - Europa 2.258
SA - Sud America 381
AF - Africa 84
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 8.653
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.737
SG - Singapore 1.416
RU - Federazione Russa 1.005
VN - Vietnam 580
CN - Cina 562
IT - Italia 397
BR - Brasile 294
HK - Hong Kong 241
DE - Germania 172
UA - Ucraina 172
FR - Francia 134
NL - Olanda 104
FI - Finlandia 93
IN - India 59
CA - Canada 58
GB - Regno Unito 57
BD - Bangladesh 47
IE - Irlanda 39
MX - Messico 34
SE - Svezia 34
AR - Argentina 29
CI - Costa d'Avorio 23
JP - Giappone 22
ZA - Sudafrica 22
PH - Filippine 17
TH - Thailandia 17
KR - Corea 16
CO - Colombia 14
PL - Polonia 14
EC - Ecuador 12
IQ - Iraq 12
VE - Venezuela 11
AT - Austria 10
ID - Indonesia 10
TR - Turchia 10
ES - Italia 9
MA - Marocco 8
PK - Pakistan 8
TW - Taiwan 8
CL - Cile 7
PY - Paraguay 6
TN - Tunisia 6
DO - Repubblica Dominicana 5
JM - Giamaica 5
SA - Arabia Saudita 5
EG - Egitto 4
LT - Lituania 4
MY - Malesia 4
NP - Nepal 4
PS - Palestinian Territory 4
UZ - Uzbekistan 4
EU - Europa 3
HN - Honduras 3
JO - Giordania 3
KE - Kenya 3
KH - Cambogia 3
PE - Perù 3
UY - Uruguay 3
AZ - Azerbaigian 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
IL - Israele 2
IR - Iran 2
KG - Kirghizistan 2
MN - Mongolia 2
NG - Nigeria 2
NO - Norvegia 2
RO - Romania 2
RS - Serbia 2
SV - El Salvador 2
TJ - Tagikistan 2
AU - Australia 1
BE - Belgio 1
BF - Burkina Faso 1
CD - Congo 1
CG - Congo 1
CV - Capo Verde 1
DK - Danimarca 1
DZ - Algeria 1
GA - Gabon 1
GN - Guinea 1
GR - Grecia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MQ - Martinica 1
NC - Nuova Caledonia 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
SI - Slovenia 1
SN - Senegal 1
Totale 8.645
Salva come PNG Salva come JPEG
Città #
Singapore 680
San Jose 427
Moscow 255
Hong Kong 224
Beijing 209
Ashburn 202
Chandler 199
Ho Chi Minh City 195
Jacksonville 167
Hanoi 131
Santa Clara 115
Woodbridge 110
Millbury 106
Amsterdam 95
Princeton 76
Los Angeles 72
Lauterbourg 69
The Dalles 63
Munich 50
Buffalo 45
Wilmington 38
Nanjing 37
New York 36
Naples 35
São Paulo 35
Hefei 34
Napoli 32
Haiphong 26
Da Nang 24
Houston 21
Council Bluffs 20
Ottawa 19
Tokyo 19
Dallas 18
Frankfurt am Main 18
Nanchang 18
Mexico City 17
Milan 17
Boston 16
Redondo Beach 16
Ann Arbor 15
Orem 15
Seattle 15
Helsinki 13
Hải Dương 13
Stockholm 13
Changsha 12
Montreal 12
San Francisco 12
Tianjin 12
Atlanta 11
Chicago 11
Rome 11
Jiaxing 10
Rio de Janeiro 10
Biên Hòa 9
Johannesburg 9
Warsaw 9
Brooklyn 8
Denver 8
Hebei 8
New Delhi 8
Toronto 8
Bangkok 7
Belo Horizonte 7
Brasília 7
Chennai 7
Falkenstein 7
London 7
Manchester 7
Norwalk 7
Rozzano 7
Salvador 7
Seoul 7
Shenyang 7
Turku 7
Baghdad 6
Bắc Ninh 6
Guayaquil 6
Joinville 6
Kunming 6
Medellín 6
Mumbai 6
Ninh Bình 6
Phoenix 6
Poplar 6
Bắc Giang 5
Can Tho 5
Casablanca 5
Nola 5
Nuremberg 5
Philadelphia 5
Pune 5
Quảng Ngãi 5
Redwood City 5
Ankara 4
Annapolis 4
Boardman 4
Charlotte 4
Crawley 4
Totale 4.454
Salva come PNG Salva come JPEG
Nome #
Manuale di Oncologia Clinica 234
null 223
The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer. 164
A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer. 156
Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study. 152
Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-a genes on in vitro transformation of human mammary epithelial cells. 150
Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer. 146
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials 144
A phase I study of paclitaxel and epirubicin, without and with filgrastim, for the treatment of platinum-resistant advanced ovarian cancer. 144
Desferioxamine increases iron depletion and apoptosis induced by ara-C of human myeloid leukaemic cells. 137
Recombinant IFN-alfa 2b treatment activates poly (ADPR) polymerase-1 (PARP-1) in KB cancer cells. 134
alpha-Interferon potentiates the growth inhibitory effects of anti-transferrin receptor monoclonal antibodies 133
Steroid hormone receptor levels and adjuvant tamoxifen in early breast cancer. Ten year results of the Naples (GUN) Study. 132
Core curriculum. Oncologia clinica 131
Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study. 130
Phorbol-12-myristate-13-acetate (PMA) induces resistance of human melanoma cells to NK and LAK-mediated cytotoxicity. 130
Interferon-alpha induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway death is antagonized by epidermal growth factor. 129
Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors. 126
Prognostic significance of circulating immune complexes in a long-term follow-up of breast cancer patients. 122
Vinorelbine + mitomycin C as second-line treatment of metastatic breast cancer: a two-stage phase 2 study. 122
A-Interferon potentiates the growth inhibitory effects of anti-transferrin receptor monoclonal antibodies. 122
Core curriculum. Oncologia clinica 121
Epidermal growth factor (EGFR) and Transferrin (TRFR) receptor upregulation is induced by arabinoside cytosine (ARA-C) on human tumor cells. 120
Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) study. 119
Advanced and Locally unresectable gastric carcinoma: five years of survival with good quality of life. 119
FOLFOX-4 in pre-treated patients with advanced transitional cell carcinoma of the bladder. 118
Expression of biomarkers modulating prostate cancer progression: Implications in the treatment of the disease 118
CD10/common acute lymphoblastic leukemia-associated antigen and adhesion factor expression is predictive for lymphokine-activated killing sensitivity of adult B-lineage acute lymphoblastic leukemia 117
Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials 116
Bryostatin 1 enhances lymphokine activated killer sensitivity and modulates the b1 integrin profile of cultured human tumor cells. 114
Studies of some immunological properties of thyroid iodoproteins 113
Breast cancer screening: characteristics and results of the Italian programmes in the Italian group for planning and evaluating breast cancer screening programmes (GISMa). 112
Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer. 112
Prolactin receptor does not correlate with oestrogen and progesterone receptors in primary breast cancer and lacks prognostic significance. Ten year results of the Naples adjuvant (GUN) study. 111
Salvage chemotherapy with CCNU and methotrexate for small cell lung cancer resistant to CAV/PE alternating chemotherapy. 110
Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A. 110
Novel toll-like receptor 9 agonist induces epidermal growth factor receptor (EGFR) inhibition and synergistic antitumour activity with EGFR inhibitors 110
Prognostic significance of necrosis, elestosis, fibrosis and inflammatory cell reaction in operable breast cancer. 108
Chemotherapy with mitomycin C and vinblastine in pretreated metastatic breast cancer. 105
cERBB-2 OVEREXPRESSION DECREASED THE BENEFIT OF ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER WITHOUT AXILLARY LIMPHONODE METASTASES 104
Overexpression of wild-type p53 ovverrides the mitogenic effect of the RIa subunit of protein kinase A in human breast cells. 104
Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. 103
Tumori urologici 102
CA 15-3 in human breast cancer. Comparison with tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA). 100
Mitomycin C and mitoxantrone in anthracycline-pretreated advanced breast cancer patients. A phase II study. 99
Prognostic significance of multifocality in primary breast cancer. 98
Adjuvant chemoendocrine therapy for early breast cancer: is it worthwhile? 98
Nuclear DNA content-derived parameters correlated with heterogeneous expression of p53 and bcl-2 proteins in clear cell renal carcinomas. 97
A predictive index of axillary nodal involvement in operable breast cancer. 97
ANTITUMOR ACTIVITY OF COMBINED BLOCKADE OF EPIDERMAL GROWTH FACTOR RECEPTOR AND PROTEIN KINASE A 95
Reversal of adriamycin resistance by recombinant alpha-interferon in multidrug-resistant human colon carcinoma LoVo-doxorubicin cells. 95
Effect of adjuvant tamoxifen and CMF on endocrine function of patients with operable breast cancer. 94
ZD1839 (Iressa): preclinical studies and pharmacology. 93
Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival. 93
Expression of biomarkers modulating prostate cancer progression: Implications in the treatment of the disease 93
Carboplatin, epirubicin and VP-16 chemotherapy in the treatment of small cell lung cancer. 92
DNA-flow cytometry (ploidy and S-phase fraction) as prognostic factor in a retrospectine series of 515 primary breast cancer. 89
EGF activates an inducible survival response via the RAS -> Erk-1/2 pathway to counteract interferon-alfa-mediated apoptosis in epidermoid cancer cells. 87
THE RIa SUBUNIT OF PROTEIN KINASE (PKA) BINDS TO GRB2 AND ALLOWS PKA INTERACTION WITH THE ACTIVATED EGF-RECEPTOR 84
Oral antisense targeting protein kinase A cooperates with taxol and inhibits tumor growth, angiogenesis and growth factors production. 84
Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer. 83
Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells. 83
The adjuvant treatment of ovarian cancer: result of the pilot study of a new combination chemotherapeutic regimen (DAC). 83
Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non-small cell lung cancer. 81
DNA-flow cytometry (ploidy and s-phase fraction) as prognostic factor in a retrospective series of 515 primary breast-cancer 80
COOPERATIVE INHIBITION OF RENAL CANCER GROWTH BY ANTI-EGF-RECEPTOR ANTIBODY AND PROTEIN KINASE A ANTISENSE OLIGONUCLEOTIDE 79
Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.). 79
Weekly docetaxel and vinorelbine (VIN-DOX) as first line treatment in patients with hormone refractory prostate cancer. 78
First-line systemic therapy for metastatic breast cancer and management of pleural effusion. 78
Carboplatin plus vinorelbine, a new well-tolerated and active regimen for the treatment of extensive-stage small-cell lung cancer: a phase II study. Gruppo Oncologico Centro-Sud-Isole. 76
SYNERGISTIC INHIBITION OF HUMAN CANCER CELL GROWTH BY CYTOTOXIC DRUGS AND MIXED BACKBONE ANTISENSE OLIGONUCLEOTIDES TARGETING PROTEIN KINASE A 73
A prognostic model that makes quantitative estimates of probability of relapse for breast cancer patients 71
Carboplatin, cisplatin and paclitaxel in the treatment of patients with epithelial ovarian cancer. 68
null 67
The prognostic value of lymphatic and blood vessel invasion in operable breast cancer. 66
Preclinical and phase I study of oxaliplatin and topotecan in combination in human cancer 65
Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-lerm follow-up. 64
LH-RH analogue Zoladex in the treatment of pre- and perimenopausal women with metastatic breast cancer (results of the Italian Cooperative Study). 63
Selecting high-risk early breast cancer patients: what to add to the number of metastatic nodes? 63
The ATAC adjuvant breast-cancer trial: six-year results of the endometrial subprotocol. 63
Phase I study of carboplatin, cisplatin, and cyclophosphamide without and with lenograstim for the treatment of ovarian cancer. 61
Phase II study of mitomycin C, etopside and vindesine (MEV) in metastatic, stage IV, non small cell lung cancer. 58
HER-2/neu receptor in prostate cancer development and progression to androgen independence. 48
Intraperitoneal mitoxantrone via temporary catheter in patients with ovarian cancer: Toxicity and feasibility evaluation 2
Phorbol 12-myristate 13-acetate (PMA) induces neuroendocrine-like differentiation and reverses doxorubicin-resistance of human colon carcinoma cells in vitro 2
Totale 8.749
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.985
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.985
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022408 9 1 2 5 1 16 2 15 44 49 111 153
2022/2023522 81 47 22 18 57 50 9 43 71 94 25 5
2023/2024348 16 58 45 30 21 42 6 34 3 4 60 29
2024/20252.184 113 180 5 9 75 82 224 149 159 182 827 179
2025/20264.022 437 269 408 374 680 159 469 252 534 258 92 90
2026/202748 48 0 0 0 0 0 0 0 0 0 0 0
Totale 8.749